Publications:

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.

Nature Medicine

Liu, David D; Schilling, Bastian B; Liu, Derek D; Sucker, Antje A; Livingstone, Elisabeth E; Jerby-Arnon, Livnat L; Zimmer, Lisa L; Gutzmer, Ralf R; Satzger, Imke I; Loquai, Carmen C; Grabbe, Stephan S; Vokes, Natalie N; Margolis, Claire A CA; Conway, Jake J; He, Meng Xiao MX; Elmarakeby, Haitham H; Dietlein, Felix F; Miao, Diana D; Tracy, Adam A; Gogas, Helen H; Goldinger, Simone M SM; Utikal, Jochen J; Blank, Christian U CU; Rauschenberg, Ricarda R; von Bubnoff, Dagmar D; Krackhardt, Angela A; Weide, Benjamin B; Haferkamp, Sebastian S; Kiecker, Felix F; Izar, Ben B; Garraway, Levi L; Regev, Aviv A; Flaherty, Keith K; Paschen, Annette A; Van Allen, Eliezer M EM; Schadendorf, Dirk D

Publication Date: 2019-12

Variant appearance in text: HR: 1513G>A

PubMed Link: 31792460

Variant Present in the following documents:

• 41591_2019_654_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors.

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Chatterjee, Saswati S

Publication Date: 2019-12-04

Variant appearance in text: HR: G505R

PubMed Link: 31735603

Variant Present in the following documents:

• Main text

View BVdb publication page

Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors".

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Rogers, Geoffrey L GL; Chen, Hsu-Yu HY; Morales, Heidy H; Cannon, Paula M PM

Publication Date: 2019-12-04

Variant appearance in text: HR: G505R

PubMed Link: 31735602

Variant Present in the following documents:

• Main text

View BVdb publication page